Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
11. November 2024
3 min to read

Female Patients with Occlusive Myocardial Infarction without ST Elevation Experience Longer Delays in Receiving Emergent Reperfusion

Female Patients with Occlusive Myocardial Infarction without ST Elevation Experience Longer Delays in Receiving Emergent Reperfusion

Overview

Up to a third of high-risk heart attacks go unrecognized by traditional ECG diagnostic criteria, causing dangerous delays—an effect even more pronounced in women, who remain understudied in this context. This analysis reveals a 4.4-hour treatment delay for initially misclassified female patients compared to males, highlighting the urgent need for modern, unbiased diagnostic solutions.

Published In: Circulation (AHA Journals) – presented at the American Heart Association (AHA) 2024 Scientific Sessions
Presented Date: November 11, 2024

Background

Sex disparities in symptom presentation are well-documented in female patients with Acute Coronary Syndrome (ACS). Moreover, nearly half of the patients with acutely occlusive myocardial infarction (OMI) do not meet the STEMI criteria at admission, leading to delays in receiving emergent reperfusion. This delay may be more pronounced in female OMI patients without ST-elevation (NSTEMI-OMI), potentially due to differences in symptom presentation and recognition.

Purpose

To investigate disparities in delays from admission ECG to percutaneous coronary intervention (PCI) between male and female patients with acute OMI stratified according to the presence of STEMI criteria.

Methods

Electrocardiograms (ECGs), laboratory and coronary angiography (CAG) data were sourced from a total of 623 consecutive OMI patients from five international cohorts from 2012 to 2023. The final diagnosis of OMI was adjudicated by two expert physicians based on all available data. Patients were stratified into STEMI-OMI and NSTEMI-OMI based on their initial admission ECG and time-to-PCI: <2hrs vs. >2hrs, respectively. Each cohort was further subdivided based on sex (male vs. female).

Results

A total of 314 STEMI-OMI patients (24% female) and 309 NSTEMI-OMI (30% female) were included in the analysis. Median ECG-to-balloon (E2B) time between STEMI-OMI and NSTEMI-OMI patients was 48 minutes and 17.1 hours, respectively (p<0.001). Female STEMI-OMI patients had an E2B of 47.0 minutes (95% CI: 30-78), compared to 50.6 minutes (95% CI: 30-72) for male patients, respectively, and did not differ significantly (p=0.85) (Fig 1A). In NSTEMI-OMI, female patients had a significantly longer median E2B time of 20.1 hours (95% CI: 10.2-48.2) as compared to 15.7 hours (95% CI: 5.6-28.0) (p=0.002) in male patients (Fig 1B).

Conclusion

The present international multi-centric validation of consecutive patients with acute coronary occlusion reveals a significant sex disparity in NSTEMI-OMI patients, with female patients experiencing a 4.4-hour delay to reperfusion compared to males. These findings highlight the need for unbiased diagnostic strategies to address sex differences in ACS presentation.


Authors: Timea Kisova, MD, BSc, Robert Herman, MD, Anthony Demolder, MD, MSc, PhD, Jakub Bahyl, Mgr, Hana Hybasek Dzurikova, MRCVS, PGCert MEd, Stephen Smith, MD, Harvey Meyers, MD, Mark Hellerman, MD, Rinaldo Lauwers, MD, David Pletnickx, MD, Dan Schelfaut, MD, Fadi El Ters, MD, Alain Tanios, MD, Fabrizio Ricci, MD, PhD, MSc, Davide Rossi, MD, Jozef Bartunek, Prof.,MUDr.,PhD, and Emanuele Barbato, Prof.,MD

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Chest Pain With Subtle But Lifesaving ECG Findings

This study presents a clinical case highlighting the diagnostic value of hyperacute T waves on electrocardiogram (ECG) for early detection of acute coronary occlusion. A 54-year-old woman presented with classic ischemic symptoms, yet her initial ECG was interpreted as normal by both automated analysis and clinician review. Closer inspection revealed subtle hyperacute T waves in the anterior leads, consistent with acute occlusion of the left anterior descending (LAD) artery. The case underscores how reliance on traditional ST-segment elevation criteria alone may delay recognition of life-threatening myocardial infarction.

AI-Enhanced Electrocardiogram for Detection of Occlusive Myocardial Infarction in High-Risk Non–ST-Segment Elevation Acute Coronary Syndrome

This study evaluates an AI-enhanced ECG model for detecting occlusive myocardial infarction (OMI) in patients with high-risk non–ST-segment elevation acute coronary syndrome, using angiography as the reference. The model improved rule-in accuracy with high specificity (78%) and reduced false-positive cath lab activations compared with standard care, while rule-out sensitivity remained limited on the initial ECG. Serial ECG analysis improved detection, supporting the use of AI as a triage aid alongside clinical judgment rather than a standalone diagnostic tool.

Join over 100,000 healthcare professionals who are already taking advantage of AI

Heart Attacks are #1 cause of death world-wide and killing about 12 milions people a year.

Clinical Definition of Problem

Contrary to popular belief, a heart attacks isn’t a blockage inside of the heart. A heart attack is a blockage of the coronary arteries supplying the heart muscle with oxygenated blood.

So let’s assume you get a blood clot here — it blocks the blood flow downstream, meaning the heart muscle doesn’t get oxygenated blood and heart tissue downstream starts to die.

Clinical Solution​

The way to fix it is relatively simple – doctors put in a stent that opens up the artery and renews blood flow. The latest clinical practice guidelines recommend that this “stenting” happens within 90 minutes from symptom onset.

If you don’t, even if you put in the stent in later, the heart tissue downstream has already been permanently damaged, which reduces the heart’s ability to pump blood. This is the leading cause of heart failure and increases 1-year mortality by two-fold.

Time is muscle.

You have just 90 minutes to diagnose the patient, bring them to the hospital and put in the stent, otherwise there is permanent damage. So problem is, that 1 in 2 heart attacks get initially misdiagnosed at the first point of contact.

Discover the future of medical work with us.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.